Markets
FWP

European ADRs Little Changed as Pharma Stocks See Mixed Fortunes

American depository receipts of European stocks were 0.01% higher at 137.64 on the Bank of New York Mellon Europe ADR Index on Friday morning.

Gainers in Continental Europe were led by Forward Pharma ( FWP ), a Danish biopharmaceutical company, up by 5.1%, Sequans Communications ( SQNS ), a French developer of chipset solutions, 2.7% higher, ERYTECH Pharma ( ERYP ), a France-based biopharmaceutical company, up by 1.9% and Trivago ( TRVG ), operates an online hotel search platform, was up by 1.8%.

In the UK, Akari Therapeutics ( AKTX ), a development-stage biopharmaceutical company, up by 2.5%, Midatech Pharma (MTP), up by 1.9% and CRH (CRH), a building materials company, trading 1.3% higher. Prudential (PUK), a financial services group, was up by 1.1%.

Decliners in Continental Europe were led by Cellectis (CLLS), a French genome engineering company, was 2.6% lower, Ascendis Pharma (ASND), a Danish clinical stage biopharmaceutical company, down by 2.3% and telecommunications companies Telecom Italia (TI) and Telecom Italia - Savings (TI.A), 1.6% and 1.4% lower, respectively.

In the UK, Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was 1.6% lower, Unilever (UL), a Dutch consumer goods company, was down by 1.2% and GW Pharmaceuticals (GWPH), a biopharmaceutical company, 1.0% lower and GlaxoSmithKline (GSK), a health care company, was 0.8% lower.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

FWP TRVG SQNS AKTX ERYP

Other Topics

Stocks